• Profile
Close

Risks and benefits of direct oral anticoagulants across the spectrum of GFR among incident and prevalent patients with atrial fibrillation

Clinical Journal of the American Society of Nephrology Jul 19, 2018

Shin JI, et al. - to warfarin in terms of bleeding risk and benefit of ischemic stroke prevention via Cox proportional hazards regression. In an electronic health record (Geisinger Health System), they created a propensity score-matched cohort of 3,206 patients using direct oral anticoagulants and 3,206 patients using warfarin from October of 2010 to February of 2017. They found that, relative to warfarin, treatment with direct oral anticoagulants for atrial fibrillation in patients with eGFR < 60 ml/min per 1.73 m2 resulted in slightly higher risk of bleeding, but similar benefits for the prevention of ischemic stroke.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay